nodes	percent_of_prediction	percent_of_DWPC	metapath
Moclobemide—CYP2C19—Rosuvastatin—atherosclerosis	0.0826	0.112	CbGbCtD
Moclobemide—CYP2C19—Simvastatin—atherosclerosis	0.0768	0.104	CbGbCtD
Moclobemide—CYP2C19—Lovastatin—atherosclerosis	0.0752	0.102	CbGbCtD
Moclobemide—CYP2D6—Niacin—atherosclerosis	0.0739	0.1	CbGbCtD
Moclobemide—CYP2C9—Rosuvastatin—atherosclerosis	0.0687	0.093	CbGbCtD
Moclobemide—CYP2C9—Simvastatin—atherosclerosis	0.0639	0.0865	CbGbCtD
Moclobemide—CYP2C9—Pravastatin—atherosclerosis	0.0625	0.0846	CbGbCtD
Moclobemide—CYP2C9—Lovastatin—atherosclerosis	0.0625	0.0846	CbGbCtD
Moclobemide—CYP2D6—Simvastatin—atherosclerosis	0.0584	0.0791	CbGbCtD
Moclobemide—CYP2D6—Pravastatin—atherosclerosis	0.0571	0.0774	CbGbCtD
Moclobemide—CYP2D6—Lovastatin—atherosclerosis	0.0571	0.0774	CbGbCtD
Moclobemide—Sleep disturbance—Simvastatin—atherosclerosis	0.00413	0.0205	CcSEcCtD
Moclobemide—Sleep disturbance—Pravastatin—atherosclerosis	0.00373	0.0185	CcSEcCtD
Moclobemide—Heartburn—Niacin—atherosclerosis	0.00309	0.0153	CcSEcCtD
Moclobemide—Hepatic enzyme increased—Rosuvastatin—atherosclerosis	0.00308	0.0153	CcSEcCtD
Moclobemide—Heartburn—Pravastatin—atherosclerosis	0.00304	0.0151	CcSEcCtD
Moclobemide—Nightmare—Rosuvastatin—atherosclerosis	0.00282	0.014	CcSEcCtD
Moclobemide—Bezafibrate—HMGCR—atherosclerosis	0.00275	0.339	CrCbGaD
Moclobemide—Bezafibrate—PPARA—atherosclerosis	0.0027	0.333	CrCbGaD
Moclobemide—Sleep disorder—Rosuvastatin—atherosclerosis	0.00245	0.0121	CcSEcCtD
Moclobemide—Nightmare—Simvastatin—atherosclerosis	0.00223	0.0111	CcSEcCtD
Moclobemide—Nightmare—Pravastatin—atherosclerosis	0.00202	0.01	CcSEcCtD
Moclobemide—Sleep disorder—Simvastatin—atherosclerosis	0.00194	0.00961	CcSEcCtD
Moclobemide—Urine output increased—Niacin—atherosclerosis	0.00192	0.00952	CcSEcCtD
Moclobemide—Hot flush—Ezetimibe—atherosclerosis	0.00188	0.00933	CcSEcCtD
Moclobemide—Menopausal symptoms—Ezetimibe—atherosclerosis	0.00187	0.00925	CcSEcCtD
Moclobemide—Polyuria—Niacin—atherosclerosis	0.00176	0.0087	CcSEcCtD
Moclobemide—Sleep disorder—Pravastatin—atherosclerosis	0.00175	0.00869	CcSEcCtD
Moclobemide—Hot flush—Pravastatin—atherosclerosis	0.00162	0.00804	CcSEcCtD
Moclobemide—Menopausal symptoms—Pravastatin—atherosclerosis	0.00161	0.00797	CcSEcCtD
Moclobemide—Gastritis—Ezetimibe—atherosclerosis	0.00156	0.00772	CcSEcCtD
Moclobemide—Migraine—Niacin—atherosclerosis	0.00152	0.00752	CcSEcCtD
Moclobemide—Gastritis—Simvastatin—atherosclerosis	0.00149	0.00737	CcSEcCtD
Moclobemide—Dry skin—Niacin—atherosclerosis	0.00141	0.007	CcSEcCtD
Moclobemide—Dry skin—Pravastatin—atherosclerosis	0.00139	0.0069	CcSEcCtD
Moclobemide—Haloperidol—HRH1—atherosclerosis	0.00137	0.169	CrCbGaD
Moclobemide—Abdominal distension—Niacin—atherosclerosis	0.00134	0.00665	CcSEcCtD
Moclobemide—Abdominal distension—Pravastatin—atherosclerosis	0.00132	0.00655	CcSEcCtD
Moclobemide—Angina pectoris—Niacin—atherosclerosis	0.0013	0.00643	CcSEcCtD
Moclobemide—Bezafibrate—PPARG—atherosclerosis	0.00129	0.16	CrCbGaD
Moclobemide—Angina pectoris—Pravastatin—atherosclerosis	0.00128	0.00633	CcSEcCtD
Moclobemide—Flatulence—Rosuvastatin—atherosclerosis	0.00126	0.00623	CcSEcCtD
Moclobemide—Dysuria—Pravastatin—atherosclerosis	0.00123	0.00608	CcSEcCtD
Moclobemide—Stomatitis—Niacin—atherosclerosis	0.00116	0.00574	CcSEcCtD
Moclobemide—Flushing—Lovastatin—atherosclerosis	0.00115	0.00571	CcSEcCtD
Moclobemide—Sweating—Niacin—atherosclerosis	0.00114	0.00565	CcSEcCtD
Moclobemide—Flushing—Ezetimibe—atherosclerosis	0.00113	0.0056	CcSEcCtD
Moclobemide—Myalgia—Rosuvastatin—atherosclerosis	0.00109	0.00538	CcSEcCtD
Moclobemide—Flushing—Simvastatin—atherosclerosis	0.00108	0.00534	CcSEcCtD
Moclobemide—Flatulence—Lovastatin—atherosclerosis	0.00107	0.00528	CcSEcCtD
Moclobemide—Dysgeusia—Lovastatin—atherosclerosis	0.00106	0.00525	CcSEcCtD
Moclobemide—Confusional state—Rosuvastatin—atherosclerosis	0.00105	0.0052	CcSEcCtD
Moclobemide—Flatulence—Ezetimibe—atherosclerosis	0.00104	0.00518	CcSEcCtD
Moclobemide—Visual impairment—Niacin—atherosclerosis	0.00103	0.00509	CcSEcCtD
Moclobemide—Vision blurred—Lovastatin—atherosclerosis	0.00102	0.00505	CcSEcCtD
Moclobemide—Tremor—Lovastatin—atherosclerosis	0.00101	0.00502	CcSEcCtD
Moclobemide—Visual impairment—Pravastatin—atherosclerosis	0.00101	0.00502	CcSEcCtD
Moclobemide—Ill-defined disorder—Lovastatin—atherosclerosis	0.001	0.00497	CcSEcCtD
Moclobemide—Flatulence—Simvastatin—atherosclerosis	0.000996	0.00494	CcSEcCtD
Moclobemide—Tinnitus—Niacin—atherosclerosis	0.000994	0.00493	CcSEcCtD
Moclobemide—Dysgeusia—Simvastatin—atherosclerosis	0.00099	0.00491	CcSEcCtD
Moclobemide—Flushing—Niacin—atherosclerosis	0.00099	0.00491	CcSEcCtD
Moclobemide—Ill-defined disorder—Ezetimibe—atherosclerosis	0.000984	0.00488	CcSEcCtD
Moclobemide—Tinnitus—Pravastatin—atherosclerosis	0.000979	0.00485	CcSEcCtD
Moclobemide—Malaise—Lovastatin—atherosclerosis	0.000975	0.00483	CcSEcCtD
Moclobemide—Flushing—Pravastatin—atherosclerosis	0.000975	0.00483	CcSEcCtD
Moclobemide—Malaise—Ezetimibe—atherosclerosis	0.000956	0.00474	CcSEcCtD
Moclobemide—Vision blurred—Simvastatin—atherosclerosis	0.000953	0.00472	CcSEcCtD
Moclobemide—Musculoskeletal discomfort—Rosuvastatin—atherosclerosis	0.000948	0.0047	CcSEcCtD
Moclobemide—Tremor—Simvastatin—atherosclerosis	0.000947	0.0047	CcSEcCtD
Moclobemide—Insomnia—Rosuvastatin—atherosclerosis	0.000942	0.00467	CcSEcCtD
Moclobemide—Ill-defined disorder—Simvastatin—atherosclerosis	0.000938	0.00465	CcSEcCtD
Moclobemide—Palpitations—Ezetimibe—atherosclerosis	0.000937	0.00464	CcSEcCtD
Moclobemide—Paraesthesia—Rosuvastatin—atherosclerosis	0.000935	0.00463	CcSEcCtD
Moclobemide—Chest pain—Lovastatin—atherosclerosis	0.00092	0.00456	CcSEcCtD
Moclobemide—Myalgia—Lovastatin—atherosclerosis	0.00092	0.00456	CcSEcCtD
Moclobemide—Anxiety—Lovastatin—atherosclerosis	0.000917	0.00455	CcSEcCtD
Moclobemide—Dyspepsia—Rosuvastatin—atherosclerosis	0.000916	0.00454	CcSEcCtD
Moclobemide—Hypertension—Ezetimibe—atherosclerosis	0.000915	0.00454	CcSEcCtD
Moclobemide—Flatulence—Niacin—atherosclerosis	0.000915	0.00454	CcSEcCtD
Moclobemide—Malaise—Simvastatin—atherosclerosis	0.000912	0.00452	CcSEcCtD
Moclobemide—Tension—Niacin—atherosclerosis	0.000911	0.00452	CcSEcCtD
Moclobemide—Discomfort—Lovastatin—atherosclerosis	0.000909	0.00451	CcSEcCtD
Moclobemide—Myalgia—Ezetimibe—atherosclerosis	0.000903	0.00447	CcSEcCtD
Moclobemide—Chest pain—Ezetimibe—atherosclerosis	0.000903	0.00447	CcSEcCtD
Moclobemide—Nervousness—Niacin—atherosclerosis	0.000902	0.00447	CcSEcCtD
Moclobemide—Flatulence—Pravastatin—atherosclerosis	0.000901	0.00447	CcSEcCtD
Moclobemide—Dry mouth—Lovastatin—atherosclerosis	0.0009	0.00446	CcSEcCtD
Moclobemide—Tension—Pravastatin—atherosclerosis	0.000897	0.00445	CcSEcCtD
Moclobemide—Dysgeusia—Pravastatin—atherosclerosis	0.000895	0.00444	CcSEcCtD
Moclobemide—Discomfort—Ezetimibe—atherosclerosis	0.000892	0.00442	CcSEcCtD
Moclobemide—Constipation—Rosuvastatin—atherosclerosis	0.00089	0.00441	CcSEcCtD
Moclobemide—Confusional state—Lovastatin—atherosclerosis	0.00089	0.00441	CcSEcCtD
Moclobemide—Nervousness—Pravastatin—atherosclerosis	0.000888	0.0044	CcSEcCtD
Moclobemide—Dry mouth—Ezetimibe—atherosclerosis	0.000883	0.00438	CcSEcCtD
Moclobemide—Vision blurred—Niacin—atherosclerosis	0.000875	0.00434	CcSEcCtD
Moclobemide—Confusional state—Ezetimibe—atherosclerosis	0.000872	0.00433	CcSEcCtD
Moclobemide—Vision blurred—Pravastatin—atherosclerosis	0.000861	0.00427	CcSEcCtD
Moclobemide—Myalgia—Simvastatin—atherosclerosis	0.000861	0.00427	CcSEcCtD
Moclobemide—Chest pain—Simvastatin—atherosclerosis	0.000861	0.00427	CcSEcCtD
Moclobemide—Feeling abnormal—Rosuvastatin—atherosclerosis	0.000858	0.00425	CcSEcCtD
Moclobemide—Anxiety—Simvastatin—atherosclerosis	0.000858	0.00425	CcSEcCtD
Moclobemide—Tremor—Pravastatin—atherosclerosis	0.000856	0.00425	CcSEcCtD
Moclobemide—Gastrointestinal pain—Rosuvastatin—atherosclerosis	0.000851	0.00422	CcSEcCtD
Moclobemide—Discomfort—Simvastatin—atherosclerosis	0.00085	0.00422	CcSEcCtD
Moclobemide—Ill-defined disorder—Pravastatin—atherosclerosis	0.000848	0.0042	CcSEcCtD
Moclobemide—Syncope—Niacin—atherosclerosis	0.000833	0.00413	CcSEcCtD
Moclobemide—Confusional state—Simvastatin—atherosclerosis	0.000832	0.00412	CcSEcCtD
Moclobemide—Urticaria—Rosuvastatin—atherosclerosis	0.000827	0.0041	CcSEcCtD
Moclobemide—Malaise—Pravastatin—atherosclerosis	0.000824	0.00409	CcSEcCtD
Moclobemide—Abdominal pain—Rosuvastatin—atherosclerosis	0.000823	0.00408	CcSEcCtD
Moclobemide—Palpitations—Niacin—atherosclerosis	0.00082	0.00407	CcSEcCtD
Moclobemide—Loss of consciousness—Niacin—atherosclerosis	0.000816	0.00405	CcSEcCtD
Moclobemide—Musculoskeletal discomfort—Lovastatin—atherosclerosis	0.000804	0.00398	CcSEcCtD
Moclobemide—Insomnia—Lovastatin—atherosclerosis	0.000798	0.00396	CcSEcCtD
Moclobemide—Paraesthesia—Lovastatin—atherosclerosis	0.000792	0.00393	CcSEcCtD
Moclobemide—Myalgia—Niacin—atherosclerosis	0.00079	0.00392	CcSEcCtD
Moclobemide—Hypertension—Pravastatin—atherosclerosis	0.000789	0.00391	CcSEcCtD
Moclobemide—Musculoskeletal discomfort—Ezetimibe—atherosclerosis	0.000788	0.00391	CcSEcCtD
Moclobemide—Dyspnoea—Lovastatin—atherosclerosis	0.000787	0.0039	CcSEcCtD
Moclobemide—Insomnia—Ezetimibe—atherosclerosis	0.000783	0.00388	CcSEcCtD
Moclobemide—Chest pain—Pravastatin—atherosclerosis	0.000778	0.00386	CcSEcCtD
Moclobemide—Myalgia—Pravastatin—atherosclerosis	0.000778	0.00386	CcSEcCtD
Moclobemide—Paraesthesia—Ezetimibe—atherosclerosis	0.000777	0.00385	CcSEcCtD
Moclobemide—Dyspepsia—Lovastatin—atherosclerosis	0.000777	0.00385	CcSEcCtD
Moclobemide—Anxiety—Pravastatin—atherosclerosis	0.000776	0.00384	CcSEcCtD
Moclobemide—Dry mouth—Niacin—atherosclerosis	0.000773	0.00383	CcSEcCtD
Moclobemide—Dyspnoea—Ezetimibe—atherosclerosis	0.000771	0.00382	CcSEcCtD
Moclobemide—Discomfort—Pravastatin—atherosclerosis	0.000769	0.00381	CcSEcCtD
Moclobemide—Decreased appetite—Lovastatin—atherosclerosis	0.000767	0.0038	CcSEcCtD
Moclobemide—Dyspepsia—Ezetimibe—atherosclerosis	0.000762	0.00378	CcSEcCtD
Moclobemide—Fatigue—Lovastatin—atherosclerosis	0.000761	0.00377	CcSEcCtD
Moclobemide—Constipation—Lovastatin—atherosclerosis	0.000754	0.00374	CcSEcCtD
Moclobemide—Confusional state—Pravastatin—atherosclerosis	0.000752	0.00373	CcSEcCtD
Moclobemide—Decreased appetite—Ezetimibe—atherosclerosis	0.000752	0.00373	CcSEcCtD
Moclobemide—Musculoskeletal discomfort—Simvastatin—atherosclerosis	0.000752	0.00373	CcSEcCtD
Moclobemide—Asthenia—Rosuvastatin—atherosclerosis	0.000747	0.0037	CcSEcCtD
Moclobemide—Insomnia—Simvastatin—atherosclerosis	0.000746	0.0037	CcSEcCtD
Moclobemide—Fatigue—Ezetimibe—atherosclerosis	0.000746	0.0037	CcSEcCtD
Moclobemide—Shock—Niacin—atherosclerosis	0.000745	0.0037	CcSEcCtD
Moclobemide—Paraesthesia—Simvastatin—atherosclerosis	0.000741	0.00367	CcSEcCtD
Moclobemide—Constipation—Ezetimibe—atherosclerosis	0.00074	0.00367	CcSEcCtD
Moclobemide—Tachycardia—Niacin—atherosclerosis	0.000739	0.00367	CcSEcCtD
Moclobemide—Pruritus—Rosuvastatin—atherosclerosis	0.000736	0.00365	CcSEcCtD
Moclobemide—Dyspnoea—Simvastatin—atherosclerosis	0.000736	0.00365	CcSEcCtD
Moclobemide—Hyperhidrosis—Niacin—atherosclerosis	0.000732	0.00363	CcSEcCtD
Moclobemide—Feeling abnormal—Lovastatin—atherosclerosis	0.000727	0.0036	CcSEcCtD
Moclobemide—Dyspepsia—Simvastatin—atherosclerosis	0.000726	0.0036	CcSEcCtD
Moclobemide—Gastrointestinal pain—Lovastatin—atherosclerosis	0.000721	0.00358	CcSEcCtD
Moclobemide—Hyperhidrosis—Pravastatin—atherosclerosis	0.000721	0.00358	CcSEcCtD
Moclobemide—Decreased appetite—Simvastatin—atherosclerosis	0.000717	0.00356	CcSEcCtD
Moclobemide—Feeling abnormal—Ezetimibe—atherosclerosis	0.000713	0.00353	CcSEcCtD
Moclobemide—Diarrhoea—Rosuvastatin—atherosclerosis	0.000712	0.00353	CcSEcCtD
Moclobemide—Fatigue—Simvastatin—atherosclerosis	0.000711	0.00353	CcSEcCtD
Moclobemide—Hypotension—Niacin—atherosclerosis	0.000708	0.00351	CcSEcCtD
Moclobemide—Gastrointestinal pain—Ezetimibe—atherosclerosis	0.000708	0.00351	CcSEcCtD
Moclobemide—Constipation—Simvastatin—atherosclerosis	0.000706	0.0035	CcSEcCtD
Moclobemide—Urticaria—Lovastatin—atherosclerosis	0.000701	0.00347	CcSEcCtD
Moclobemide—Abdominal pain—Lovastatin—atherosclerosis	0.000697	0.00346	CcSEcCtD
Moclobemide—Musculoskeletal discomfort—Niacin—atherosclerosis	0.00069	0.00342	CcSEcCtD
Moclobemide—Dizziness—Rosuvastatin—atherosclerosis	0.000688	0.00341	CcSEcCtD
Moclobemide—Urticaria—Ezetimibe—atherosclerosis	0.000687	0.00341	CcSEcCtD
Moclobemide—Insomnia—Niacin—atherosclerosis	0.000685	0.0034	CcSEcCtD
Moclobemide—Abdominal pain—Ezetimibe—atherosclerosis	0.000684	0.00339	CcSEcCtD
Moclobemide—Paraesthesia—Niacin—atherosclerosis	0.00068	0.00337	CcSEcCtD
Moclobemide—Feeling abnormal—Simvastatin—atherosclerosis	0.00068	0.00337	CcSEcCtD
Moclobemide—Musculoskeletal discomfort—Pravastatin—atherosclerosis	0.00068	0.00337	CcSEcCtD
Moclobemide—Dyspnoea—Niacin—atherosclerosis	0.000676	0.00335	CcSEcCtD
Moclobemide—Gastrointestinal pain—Simvastatin—atherosclerosis	0.000675	0.00334	CcSEcCtD
Moclobemide—Insomnia—Pravastatin—atherosclerosis	0.000675	0.00334	CcSEcCtD
Moclobemide—Somnolence—Niacin—atherosclerosis	0.000674	0.00334	CcSEcCtD
Moclobemide—Paraesthesia—Pravastatin—atherosclerosis	0.00067	0.00332	CcSEcCtD
Moclobemide—Dyspepsia—Niacin—atherosclerosis	0.000667	0.00331	CcSEcCtD
Moclobemide—Dyspnoea—Pravastatin—atherosclerosis	0.000665	0.0033	CcSEcCtD
Moclobemide—Decreased appetite—Niacin—atherosclerosis	0.000659	0.00327	CcSEcCtD
Moclobemide—Dyspepsia—Pravastatin—atherosclerosis	0.000657	0.00326	CcSEcCtD
Moclobemide—Rash—Rosuvastatin—atherosclerosis	0.000656	0.00325	CcSEcCtD
Moclobemide—Dermatitis—Rosuvastatin—atherosclerosis	0.000656	0.00325	CcSEcCtD
Moclobemide—Urticaria—Simvastatin—atherosclerosis	0.000656	0.00325	CcSEcCtD
Moclobemide—Abdominal pain—Simvastatin—atherosclerosis	0.000652	0.00323	CcSEcCtD
Moclobemide—Headache—Rosuvastatin—atherosclerosis	0.000652	0.00323	CcSEcCtD
Moclobemide—Decreased appetite—Pravastatin—atherosclerosis	0.000649	0.00321	CcSEcCtD
Moclobemide—Fatigue—Pravastatin—atherosclerosis	0.000643	0.00319	CcSEcCtD
Moclobemide—Constipation—Pravastatin—atherosclerosis	0.000638	0.00316	CcSEcCtD
Moclobemide—Asthenia—Lovastatin—atherosclerosis	0.000633	0.00314	CcSEcCtD
Moclobemide—Pruritus—Lovastatin—atherosclerosis	0.000624	0.00309	CcSEcCtD
Moclobemide—Asthenia—Ezetimibe—atherosclerosis	0.000621	0.00308	CcSEcCtD
Moclobemide—Gastrointestinal pain—Niacin—atherosclerosis	0.00062	0.00307	CcSEcCtD
Moclobemide—Nausea—Rosuvastatin—atherosclerosis	0.000618	0.00307	CcSEcCtD
Moclobemide—Feeling abnormal—Pravastatin—atherosclerosis	0.000615	0.00305	CcSEcCtD
Moclobemide—Pruritus—Ezetimibe—atherosclerosis	0.000612	0.00303	CcSEcCtD
Moclobemide—Gastrointestinal pain—Pravastatin—atherosclerosis	0.00061	0.00302	CcSEcCtD
Moclobemide—Diarrhoea—Lovastatin—atherosclerosis	0.000604	0.00299	CcSEcCtD
Moclobemide—Urticaria—Niacin—atherosclerosis	0.000602	0.00298	CcSEcCtD
Moclobemide—Abdominal pain—Niacin—atherosclerosis	0.000599	0.00297	CcSEcCtD
Moclobemide—Urticaria—Pravastatin—atherosclerosis	0.000593	0.00294	CcSEcCtD
Moclobemide—Asthenia—Simvastatin—atherosclerosis	0.000592	0.00293	CcSEcCtD
Moclobemide—Diarrhoea—Ezetimibe—atherosclerosis	0.000592	0.00293	CcSEcCtD
Moclobemide—Abdominal pain—Pravastatin—atherosclerosis	0.00059	0.00292	CcSEcCtD
Moclobemide—Pruritus—Simvastatin—atherosclerosis	0.000584	0.00289	CcSEcCtD
Moclobemide—Dizziness—Lovastatin—atherosclerosis	0.000583	0.00289	CcSEcCtD
Moclobemide—Dizziness—Ezetimibe—atherosclerosis	0.000572	0.00284	CcSEcCtD
Moclobemide—Diarrhoea—Simvastatin—atherosclerosis	0.000565	0.0028	CcSEcCtD
Moclobemide—Vomiting—Lovastatin—atherosclerosis	0.000561	0.00278	CcSEcCtD
Moclobemide—Rash—Lovastatin—atherosclerosis	0.000556	0.00276	CcSEcCtD
Moclobemide—Dermatitis—Lovastatin—atherosclerosis	0.000556	0.00275	CcSEcCtD
Moclobemide—Headache—Lovastatin—atherosclerosis	0.000553	0.00274	CcSEcCtD
Moclobemide—Vomiting—Ezetimibe—atherosclerosis	0.00055	0.00273	CcSEcCtD
Moclobemide—Dizziness—Simvastatin—atherosclerosis	0.000546	0.00271	CcSEcCtD
Moclobemide—Rash—Ezetimibe—atherosclerosis	0.000546	0.0027	CcSEcCtD
Moclobemide—Dermatitis—Ezetimibe—atherosclerosis	0.000545	0.0027	CcSEcCtD
Moclobemide—Asthenia—Niacin—atherosclerosis	0.000544	0.00269	CcSEcCtD
Moclobemide—Headache—Ezetimibe—atherosclerosis	0.000542	0.00269	CcSEcCtD
Moclobemide—Pruritus—Niacin—atherosclerosis	0.000536	0.00266	CcSEcCtD
Moclobemide—Asthenia—Pravastatin—atherosclerosis	0.000535	0.00265	CcSEcCtD
Moclobemide—Pruritus—Pravastatin—atherosclerosis	0.000528	0.00262	CcSEcCtD
Moclobemide—Vomiting—Simvastatin—atherosclerosis	0.000525	0.0026	CcSEcCtD
Moclobemide—Nausea—Lovastatin—atherosclerosis	0.000524	0.0026	CcSEcCtD
Moclobemide—Rash—Simvastatin—atherosclerosis	0.00052	0.00258	CcSEcCtD
Moclobemide—Dermatitis—Simvastatin—atherosclerosis	0.00052	0.00258	CcSEcCtD
Moclobemide—Diarrhoea—Niacin—atherosclerosis	0.000518	0.00257	CcSEcCtD
Moclobemide—Headache—Simvastatin—atherosclerosis	0.000517	0.00256	CcSEcCtD
Moclobemide—Nausea—Ezetimibe—atherosclerosis	0.000514	0.00255	CcSEcCtD
Moclobemide—Diarrhoea—Pravastatin—atherosclerosis	0.00051	0.00253	CcSEcCtD
Moclobemide—Dizziness—Niacin—atherosclerosis	0.000501	0.00248	CcSEcCtD
Moclobemide—Dizziness—Pravastatin—atherosclerosis	0.000493	0.00245	CcSEcCtD
Moclobemide—Nausea—Simvastatin—atherosclerosis	0.00049	0.00243	CcSEcCtD
Moclobemide—Vomiting—Niacin—atherosclerosis	0.000482	0.00239	CcSEcCtD
Moclobemide—Rash—Niacin—atherosclerosis	0.000478	0.00237	CcSEcCtD
Moclobemide—Dermatitis—Niacin—atherosclerosis	0.000477	0.00237	CcSEcCtD
Moclobemide—Headache—Niacin—atherosclerosis	0.000475	0.00235	CcSEcCtD
Moclobemide—Vomiting—Pravastatin—atherosclerosis	0.000474	0.00235	CcSEcCtD
Moclobemide—Rash—Pravastatin—atherosclerosis	0.00047	0.00233	CcSEcCtD
Moclobemide—Dermatitis—Pravastatin—atherosclerosis	0.00047	0.00233	CcSEcCtD
Moclobemide—Headache—Pravastatin—atherosclerosis	0.000467	0.00232	CcSEcCtD
Moclobemide—Nausea—Niacin—atherosclerosis	0.00045	0.00223	CcSEcCtD
Moclobemide—Nausea—Pravastatin—atherosclerosis	0.000443	0.0022	CcSEcCtD
Moclobemide—CYP1A2—Metabolism of lipids and lipoproteins—APOC3—atherosclerosis	3.01e-05	0.000584	CbGpPWpGaD
Moclobemide—CYP1A2—Metabolism of lipids and lipoproteins—LDLR—atherosclerosis	2.99e-05	0.000581	CbGpPWpGaD
Moclobemide—MAOB—Metabolism—APOE—atherosclerosis	2.98e-05	0.000579	CbGpPWpGaD
Moclobemide—MAOB—Metabolism—CAV1—atherosclerosis	2.95e-05	0.000573	CbGpPWpGaD
Moclobemide—MAOB—Metabolism—APOA1—atherosclerosis	2.95e-05	0.000572	CbGpPWpGaD
Moclobemide—CYP1A2—Metabolism of lipids and lipoproteins—CETP—atherosclerosis	2.92e-05	0.000567	CbGpPWpGaD
Moclobemide—CYP2C19—Metabolism—ABCG1—atherosclerosis	2.87e-05	0.000558	CbGpPWpGaD
Moclobemide—MAOA—Metabolism—ABCA1—atherosclerosis	2.84e-05	0.000552	CbGpPWpGaD
Moclobemide—CYP1A2—Metabolism—LTA4H—atherosclerosis	2.83e-05	0.00055	CbGpPWpGaD
Moclobemide—CYP1A2—Metabolism—ABCG8—atherosclerosis	2.83e-05	0.00055	CbGpPWpGaD
Moclobemide—CYP1A2—Metabolism of lipids and lipoproteins—SCARB1—atherosclerosis	2.8e-05	0.000543	CbGpPWpGaD
Moclobemide—CYP2C9—Metabolism of lipids and lipoproteins—ABCA1—atherosclerosis	2.75e-05	0.000535	CbGpPWpGaD
Moclobemide—CYP2C19—Metabolism—FABP4—atherosclerosis	2.7e-05	0.000525	CbGpPWpGaD
Moclobemide—CYP2C19—Metabolism—LCAT—atherosclerosis	2.7e-05	0.000525	CbGpPWpGaD
Moclobemide—MAOB—Metabolism—PIK3CG—atherosclerosis	2.69e-05	0.000522	CbGpPWpGaD
Moclobemide—CYP2C19—Metabolism—APOA4—atherosclerosis	2.65e-05	0.000515	CbGpPWpGaD
Moclobemide—CYP2D6—Metabolism—ABCG1—atherosclerosis	2.64e-05	0.000513	CbGpPWpGaD
Moclobemide—CYP1A2—Metabolism of lipids and lipoproteins—HMGCR—atherosclerosis	2.64e-05	0.000513	CbGpPWpGaD
Moclobemide—CYP2C9—Metabolism—ABCG1—atherosclerosis	2.62e-05	0.000509	CbGpPWpGaD
Moclobemide—CYP2C19—Metabolism—CYP7A1—atherosclerosis	2.61e-05	0.000506	CbGpPWpGaD
Moclobemide—MAOB—Metabolism—PPARG—atherosclerosis	2.6e-05	0.000504	CbGpPWpGaD
Moclobemide—MAOB—Metabolism—INS—atherosclerosis	2.55e-05	0.000494	CbGpPWpGaD
Moclobemide—CYP2D6—Metabolism—FABP4—atherosclerosis	2.49e-05	0.000483	CbGpPWpGaD
Moclobemide—CYP2D6—Metabolism—LCAT—atherosclerosis	2.49e-05	0.000483	CbGpPWpGaD
Moclobemide—CYP2C19—Metabolism of lipids and lipoproteins—APOB—atherosclerosis	2.48e-05	0.000482	CbGpPWpGaD
Moclobemide—CYP2C9—Metabolism—LCAT—atherosclerosis	2.46e-05	0.000478	CbGpPWpGaD
Moclobemide—CYP2C9—Metabolism—FABP4—atherosclerosis	2.46e-05	0.000478	CbGpPWpGaD
Moclobemide—CYP2D6—Metabolism—APOA4—atherosclerosis	2.44e-05	0.000474	CbGpPWpGaD
Moclobemide—MAOA—Metabolism—HMOX1—atherosclerosis	2.44e-05	0.000474	CbGpPWpGaD
Moclobemide—CYP2C9—Metabolism—APOA4—atherosclerosis	2.42e-05	0.00047	CbGpPWpGaD
Moclobemide—CYP2C19—Metabolism—CYP27A1—atherosclerosis	2.41e-05	0.000468	CbGpPWpGaD
Moclobemide—CYP2D6—Metabolism—CYP7A1—atherosclerosis	2.4e-05	0.000465	CbGpPWpGaD
Moclobemide—CYP2C9—Metabolism—CYP7A1—atherosclerosis	2.38e-05	0.000461	CbGpPWpGaD
Moclobemide—CYP2C19—Metabolism of lipids and lipoproteins—LPL—atherosclerosis	2.37e-05	0.00046	CbGpPWpGaD
Moclobemide—CYP1A2—Metabolism of lipids and lipoproteins—ABCA1—atherosclerosis	2.35e-05	0.000457	CbGpPWpGaD
Moclobemide—MAOA—Metabolism—APOB—atherosclerosis	2.34e-05	0.000454	CbGpPWpGaD
Moclobemide—MAOB—Metabolism—ALB—atherosclerosis	2.33e-05	0.000453	CbGpPWpGaD
Moclobemide—CYP2C19—Metabolism of lipids and lipoproteins—GPX1—atherosclerosis	2.31e-05	0.000449	CbGpPWpGaD
Moclobemide—CYP2C19—Metabolism—PLA2G2A—atherosclerosis	2.28e-05	0.000443	CbGpPWpGaD
Moclobemide—CYP2C19—Metabolism—APOA2—atherosclerosis	2.28e-05	0.000443	CbGpPWpGaD
Moclobemide—CYP2C19—Metabolism—ALOX15—atherosclerosis	2.28e-05	0.000443	CbGpPWpGaD
Moclobemide—CYP2C19—Metabolism—ALOX5AP—atherosclerosis	2.28e-05	0.000443	CbGpPWpGaD
Moclobemide—MAOA—Metabolism—GSTM1—atherosclerosis	2.27e-05	0.000441	CbGpPWpGaD
Moclobemide—CYP2C9—Metabolism of lipids and lipoproteins—APOB—atherosclerosis	2.26e-05	0.00044	CbGpPWpGaD
Moclobemide—CYP2C19—Metabolism—ABCG5—atherosclerosis	2.26e-05	0.000438	CbGpPWpGaD
Moclobemide—CYP2C19—Metabolism of lipids and lipoproteins—CD36—atherosclerosis	2.25e-05	0.000437	CbGpPWpGaD
Moclobemide—CYP1A2—Metabolism—ABCG1—atherosclerosis	2.24e-05	0.000435	CbGpPWpGaD
Moclobemide—MAOB—Metabolism—NOS3—atherosclerosis	2.23e-05	0.000433	CbGpPWpGaD
Moclobemide—MAOA—Metabolism—LPL—atherosclerosis	2.23e-05	0.000433	CbGpPWpGaD
Moclobemide—CYP2D6—Metabolism—CYP27A1—atherosclerosis	2.22e-05	0.00043	CbGpPWpGaD
Moclobemide—CYP2C9—Metabolism—CYP27A1—atherosclerosis	2.2e-05	0.000426	CbGpPWpGaD
Moclobemide—CYP2C19—Metabolism—LPA—atherosclerosis	2.18e-05	0.000423	CbGpPWpGaD
Moclobemide—MAOA—Metabolism—GPX1—atherosclerosis	2.18e-05	0.000423	CbGpPWpGaD
Moclobemide—CYP2C9—Metabolism of lipids and lipoproteins—LPL—atherosclerosis	2.16e-05	0.00042	CbGpPWpGaD
Moclobemide—MAOA—Metabolism—CD36—atherosclerosis	2.12e-05	0.000412	CbGpPWpGaD
Moclobemide—CYP2C19—Metabolism—BGN—atherosclerosis	2.11e-05	0.00041	CbGpPWpGaD
Moclobemide—CYP2C9—Metabolism of lipids and lipoproteins—GPX1—atherosclerosis	2.11e-05	0.00041	CbGpPWpGaD
Moclobemide—CYP1A2—Metabolism—FABP4—atherosclerosis	2.11e-05	0.000409	CbGpPWpGaD
Moclobemide—CYP1A2—Metabolism—LCAT—atherosclerosis	2.11e-05	0.000409	CbGpPWpGaD
Moclobemide—CYP2D6—Metabolism—ALOX15—atherosclerosis	2.1e-05	0.000408	CbGpPWpGaD
Moclobemide—CYP2D6—Metabolism—ALOX5AP—atherosclerosis	2.1e-05	0.000408	CbGpPWpGaD
Moclobemide—CYP2D6—Metabolism—PLA2G2A—atherosclerosis	2.1e-05	0.000408	CbGpPWpGaD
Moclobemide—CYP2D6—Metabolism—APOA2—atherosclerosis	2.1e-05	0.000408	CbGpPWpGaD
Moclobemide—CYP2C19—Metabolism of lipids and lipoproteins—PPARA—atherosclerosis	2.09e-05	0.000407	CbGpPWpGaD
Moclobemide—CYP2C19—Metabolism—APOA5—atherosclerosis	2.09e-05	0.000405	CbGpPWpGaD
Moclobemide—CYP2C9—Metabolism—APOA2—atherosclerosis	2.08e-05	0.000404	CbGpPWpGaD
Moclobemide—CYP2C9—Metabolism—ALOX15—atherosclerosis	2.08e-05	0.000404	CbGpPWpGaD
Moclobemide—CYP2C9—Metabolism—ALOX5AP—atherosclerosis	2.08e-05	0.000404	CbGpPWpGaD
Moclobemide—CYP2C9—Metabolism—PLA2G2A—atherosclerosis	2.08e-05	0.000404	CbGpPWpGaD
Moclobemide—CYP2D6—Metabolism—ABCG5—atherosclerosis	2.07e-05	0.000403	CbGpPWpGaD
Moclobemide—CYP1A2—Metabolism—APOA4—atherosclerosis	2.07e-05	0.000401	CbGpPWpGaD
Moclobemide—CYP2C9—Metabolism—ABCG5—atherosclerosis	2.06e-05	0.000399	CbGpPWpGaD
Moclobemide—CYP2C9—Metabolism of lipids and lipoproteins—CD36—atherosclerosis	2.05e-05	0.000399	CbGpPWpGaD
Moclobemide—MAOB—Metabolism—PTGS2—atherosclerosis	2.04e-05	0.000396	CbGpPWpGaD
Moclobemide—CYP1A2—Metabolism—CYP7A1—atherosclerosis	2.03e-05	0.000394	CbGpPWpGaD
Moclobemide—CYP2C19—Metabolism of lipids and lipoproteins—AGT—atherosclerosis	2.03e-05	0.000394	CbGpPWpGaD
Moclobemide—CYP2C19—Metabolism—PLA2G1B—atherosclerosis	2.01e-05	0.00039	CbGpPWpGaD
Moclobemide—MAOA—Metabolism—MTHFR—atherosclerosis	2.01e-05	0.00039	CbGpPWpGaD
Moclobemide—CYP2D6—Metabolism—LPA—atherosclerosis	2e-05	0.000389	CbGpPWpGaD
Moclobemide—CYP2C19—Metabolism of lipids and lipoproteins—APOE—atherosclerosis	1.99e-05	0.000386	CbGpPWpGaD
Moclobemide—CYP2C9—Metabolism—LPA—atherosclerosis	1.99e-05	0.000386	CbGpPWpGaD
Moclobemide—MAOA—Metabolism—PPARA—atherosclerosis	1.97e-05	0.000383	CbGpPWpGaD
Moclobemide—CYP2C19—Metabolism of lipids and lipoproteins—CAV1—atherosclerosis	1.97e-05	0.000382	CbGpPWpGaD
Moclobemide—CYP2C19—Metabolism of lipids and lipoproteins—APOA1—atherosclerosis	1.96e-05	0.000381	CbGpPWpGaD
Moclobemide—CYP2C19—Metabolism—ALOX5—atherosclerosis	1.94e-05	0.000377	CbGpPWpGaD
Moclobemide—CYP2D6—Metabolism—BGN—atherosclerosis	1.94e-05	0.000377	CbGpPWpGaD
Moclobemide—CYP1A2—Metabolism of lipids and lipoproteins—APOB—atherosclerosis	1.93e-05	0.000376	CbGpPWpGaD
Moclobemide—CYP2C9—Metabolism—BGN—atherosclerosis	1.92e-05	0.000373	CbGpPWpGaD
Moclobemide—CYP2D6—Metabolism—APOA5—atherosclerosis	1.92e-05	0.000373	CbGpPWpGaD
Moclobemide—CYP2C9—Metabolism of lipids and lipoproteins—PPARA—atherosclerosis	1.91e-05	0.000371	CbGpPWpGaD
Moclobemide—MAOA—Metabolism—AGT—atherosclerosis	1.91e-05	0.000371	CbGpPWpGaD
Moclobemide—CYP2C9—Metabolism—APOA5—atherosclerosis	1.9e-05	0.00037	CbGpPWpGaD
Moclobemide—CYP1A2—Metabolism—CYP27A1—atherosclerosis	1.88e-05	0.000364	CbGpPWpGaD
Moclobemide—MAOA—Metabolism—APOE—atherosclerosis	1.87e-05	0.000363	CbGpPWpGaD
Moclobemide—MAOA—Metabolism—CAV1—atherosclerosis	1.85e-05	0.00036	CbGpPWpGaD
Moclobemide—CYP2C9—Metabolism of lipids and lipoproteins—AGT—atherosclerosis	1.85e-05	0.000359	CbGpPWpGaD
Moclobemide—CYP2D6—Metabolism—PLA2G1B—atherosclerosis	1.85e-05	0.000359	CbGpPWpGaD
Moclobemide—MAOA—Metabolism—APOA1—atherosclerosis	1.85e-05	0.000359	CbGpPWpGaD
Moclobemide—CYP1A2—Metabolism of lipids and lipoproteins—LPL—atherosclerosis	1.85e-05	0.000359	CbGpPWpGaD
Moclobemide—CYP2C9—Metabolism—PLA2G1B—atherosclerosis	1.83e-05	0.000356	CbGpPWpGaD
Moclobemide—CYP2C9—Metabolism of lipids and lipoproteins—APOE—atherosclerosis	1.81e-05	0.000352	CbGpPWpGaD
Moclobemide—CYP1A2—Metabolism of lipids and lipoproteins—GPX1—atherosclerosis	1.8e-05	0.00035	CbGpPWpGaD
Moclobemide—CYP2C9—Metabolism of lipids and lipoproteins—CAV1—atherosclerosis	1.8e-05	0.000349	CbGpPWpGaD
Moclobemide—CYP2C19—Metabolism of lipids and lipoproteins—PIK3CG—atherosclerosis	1.79e-05	0.000348	CbGpPWpGaD
Moclobemide—CYP2C9—Metabolism of lipids and lipoproteins—APOA1—atherosclerosis	1.79e-05	0.000348	CbGpPWpGaD
Moclobemide—CYP2D6—Metabolism—ALOX5—atherosclerosis	1.79e-05	0.000347	CbGpPWpGaD
Moclobemide—CYP1A2—Metabolism—ALOX5AP—atherosclerosis	1.78e-05	0.000345	CbGpPWpGaD
Moclobemide—CYP1A2—Metabolism—APOA2—atherosclerosis	1.78e-05	0.000345	CbGpPWpGaD
Moclobemide—CYP1A2—Metabolism—ALOX15—atherosclerosis	1.78e-05	0.000345	CbGpPWpGaD
Moclobemide—CYP1A2—Metabolism—PLA2G2A—atherosclerosis	1.78e-05	0.000345	CbGpPWpGaD
Moclobemide—CYP2C9—Metabolism—ALOX5—atherosclerosis	1.77e-05	0.000344	CbGpPWpGaD
Moclobemide—CYP1A2—Metabolism—ABCG5—atherosclerosis	1.76e-05	0.000341	CbGpPWpGaD
Moclobemide—CYP1A2—Metabolism of lipids and lipoproteins—CD36—atherosclerosis	1.76e-05	0.000341	CbGpPWpGaD
Moclobemide—CYP2C19—Metabolism—NAMPT—atherosclerosis	1.74e-05	0.000338	CbGpPWpGaD
Moclobemide—CYP2C19—Metabolism of lipids and lipoproteins—PPARG—atherosclerosis	1.73e-05	0.000336	CbGpPWpGaD
Moclobemide—CYP2C19—Metabolism—LIPC—atherosclerosis	1.73e-05	0.000336	CbGpPWpGaD
Moclobemide—CYP2C19—Metabolism—APOC3—atherosclerosis	1.72e-05	0.000334	CbGpPWpGaD
Moclobemide—CYP2C19—Metabolism—LDLR—atherosclerosis	1.71e-05	0.000332	CbGpPWpGaD
Moclobemide—CYP1A2—Metabolism—LPA—atherosclerosis	1.7e-05	0.00033	CbGpPWpGaD
Moclobemide—MAOA—Metabolism—PIK3CG—atherosclerosis	1.69e-05	0.000328	CbGpPWpGaD
Moclobemide—CYP2C19—Metabolism—CETP—atherosclerosis	1.67e-05	0.000324	CbGpPWpGaD
Moclobemide—CYP1A2—Metabolism—BGN—atherosclerosis	1.64e-05	0.000319	CbGpPWpGaD
Moclobemide—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CG—atherosclerosis	1.64e-05	0.000318	CbGpPWpGaD
Moclobemide—CYP1A2—Metabolism of lipids and lipoproteins—PPARA—atherosclerosis	1.63e-05	0.000317	CbGpPWpGaD
Moclobemide—MAOA—Metabolism—PPARG—atherosclerosis	1.63e-05	0.000316	CbGpPWpGaD
Moclobemide—CYP1A2—Metabolism—APOA5—atherosclerosis	1.63e-05	0.000316	CbGpPWpGaD
Moclobemide—CYP2D6—Metabolism—NAMPT—atherosclerosis	1.6e-05	0.000311	CbGpPWpGaD
Moclobemide—CYP2C19—Metabolism—SCARB1—atherosclerosis	1.6e-05	0.00031	CbGpPWpGaD
Moclobemide—MAOA—Metabolism—INS—atherosclerosis	1.6e-05	0.00031	CbGpPWpGaD
Moclobemide—CYP2D6—Metabolism—LIPC—atherosclerosis	1.59e-05	0.000309	CbGpPWpGaD
Moclobemide—CYP2C9—Metabolism—NAMPT—atherosclerosis	1.59e-05	0.000308	CbGpPWpGaD
Moclobemide—CYP2D6—Metabolism—APOC3—atherosclerosis	1.58e-05	0.000307	CbGpPWpGaD
Moclobemide—CYP1A2—Metabolism of lipids and lipoproteins—AGT—atherosclerosis	1.58e-05	0.000307	CbGpPWpGaD
Moclobemide—CYP2C9—Metabolism of lipids and lipoproteins—PPARG—atherosclerosis	1.58e-05	0.000306	CbGpPWpGaD
Moclobemide—CYP2C9—Metabolism—LIPC—atherosclerosis	1.58e-05	0.000306	CbGpPWpGaD
Moclobemide—CYP2D6—Metabolism—LDLR—atherosclerosis	1.57e-05	0.000305	CbGpPWpGaD
Moclobemide—CYP2C9—Metabolism—APOC3—atherosclerosis	1.57e-05	0.000304	CbGpPWpGaD
Moclobemide—CYP1A2—Metabolism—PLA2G1B—atherosclerosis	1.57e-05	0.000304	CbGpPWpGaD
Moclobemide—CYP2C9—Metabolism—LDLR—atherosclerosis	1.56e-05	0.000303	CbGpPWpGaD
Moclobemide—CYP2C19—Metabolism of lipids and lipoproteins—ALB—atherosclerosis	1.56e-05	0.000302	CbGpPWpGaD
Moclobemide—CYP1A2—Metabolism of lipids and lipoproteins—APOE—atherosclerosis	1.55e-05	0.000301	CbGpPWpGaD
Moclobemide—CYP2D6—Metabolism—CETP—atherosclerosis	1.54e-05	0.000298	CbGpPWpGaD
Moclobemide—CYP1A2—Metabolism of lipids and lipoproteins—CAV1—atherosclerosis	1.53e-05	0.000298	CbGpPWpGaD
Moclobemide—CYP1A2—Metabolism of lipids and lipoproteins—APOA1—atherosclerosis	1.53e-05	0.000297	CbGpPWpGaD
Moclobemide—CYP2C9—Metabolism—CETP—atherosclerosis	1.52e-05	0.000296	CbGpPWpGaD
Moclobemide—CYP1A2—Metabolism—ALOX5—atherosclerosis	1.51e-05	0.000294	CbGpPWpGaD
Moclobemide—CYP2C19—Metabolism—HMGCR—atherosclerosis	1.51e-05	0.000293	CbGpPWpGaD
Moclobemide—CYP2D6—Metabolism—SCARB1—atherosclerosis	1.47e-05	0.000285	CbGpPWpGaD
Moclobemide—MAOA—Metabolism—ALB—atherosclerosis	1.46e-05	0.000284	CbGpPWpGaD
Moclobemide—CYP2C9—Metabolism—SCARB1—atherosclerosis	1.46e-05	0.000283	CbGpPWpGaD
Moclobemide—CYP2C9—Metabolism of lipids and lipoproteins—ALB—atherosclerosis	1.42e-05	0.000276	CbGpPWpGaD
Moclobemide—MAOA—Metabolism—NOS3—atherosclerosis	1.4e-05	0.000272	CbGpPWpGaD
Moclobemide—CYP1A2—Metabolism of lipids and lipoproteins—PIK3CG—atherosclerosis	1.4e-05	0.000271	CbGpPWpGaD
Moclobemide—CYP2D6—Metabolism—HMGCR—atherosclerosis	1.39e-05	0.00027	CbGpPWpGaD
Moclobemide—CYP2C9—Metabolism—HMGCR—atherosclerosis	1.38e-05	0.000267	CbGpPWpGaD
Moclobemide—CYP2C19—Metabolism of lipids and lipoproteins—PTGS2—atherosclerosis	1.36e-05	0.000264	CbGpPWpGaD
Moclobemide—CYP1A2—Metabolism—NAMPT—atherosclerosis	1.36e-05	0.000263	CbGpPWpGaD
Moclobemide—CYP1A2—Metabolism of lipids and lipoproteins—PPARG—atherosclerosis	1.35e-05	0.000262	CbGpPWpGaD
Moclobemide—CYP1A2—Metabolism—LIPC—atherosclerosis	1.35e-05	0.000262	CbGpPWpGaD
Moclobemide—CYP2C19—Metabolism—ABCA1—atherosclerosis	1.35e-05	0.000261	CbGpPWpGaD
Moclobemide—CYP1A2—Metabolism—APOC3—atherosclerosis	1.34e-05	0.00026	CbGpPWpGaD
Moclobemide—CYP1A2—Metabolism—LDLR—atherosclerosis	1.33e-05	0.000259	CbGpPWpGaD
Moclobemide—CYP1A2—Metabolism—CETP—atherosclerosis	1.3e-05	0.000253	CbGpPWpGaD
Moclobemide—MAOA—Metabolism—PTGS2—atherosclerosis	1.28e-05	0.000249	CbGpPWpGaD
Moclobemide—CYP1A2—Metabolism—SCARB1—atherosclerosis	1.25e-05	0.000242	CbGpPWpGaD
Moclobemide—CYP2C9—Metabolism of lipids and lipoproteins—PTGS2—atherosclerosis	1.24e-05	0.000241	CbGpPWpGaD
Moclobemide—CYP2D6—Metabolism—ABCA1—atherosclerosis	1.24e-05	0.00024	CbGpPWpGaD
Moclobemide—CYP2C9—Metabolism—ABCA1—atherosclerosis	1.23e-05	0.000238	CbGpPWpGaD
Moclobemide—CYP1A2—Metabolism of lipids and lipoproteins—ALB—atherosclerosis	1.21e-05	0.000235	CbGpPWpGaD
Moclobemide—CYP1A2—Metabolism—HMGCR—atherosclerosis	1.18e-05	0.000228	CbGpPWpGaD
Moclobemide—CYP2C19—Metabolism—HMOX1—atherosclerosis	1.15e-05	0.000224	CbGpPWpGaD
Moclobemide—CYP2C19—Metabolism—APOB—atherosclerosis	1.11e-05	0.000215	CbGpPWpGaD
Moclobemide—CYP2C19—Metabolism—GSTM1—atherosclerosis	1.08e-05	0.000209	CbGpPWpGaD
Moclobemide—CYP2D6—Metabolism—HMOX1—atherosclerosis	1.06e-05	0.000206	CbGpPWpGaD
Moclobemide—CYP1A2—Metabolism of lipids and lipoproteins—PTGS2—atherosclerosis	1.06e-05	0.000206	CbGpPWpGaD
Moclobemide—CYP2C19—Metabolism—LPL—atherosclerosis	1.06e-05	0.000205	CbGpPWpGaD
Moclobemide—CYP2C9—Metabolism—HMOX1—atherosclerosis	1.05e-05	0.000204	CbGpPWpGaD
Moclobemide—CYP1A2—Metabolism—ABCA1—atherosclerosis	1.05e-05	0.000204	CbGpPWpGaD
Moclobemide—CYP2C19—Metabolism—GPX1—atherosclerosis	1.03e-05	0.0002	CbGpPWpGaD
Moclobemide—MAOB—Metabolism—AKT1—atherosclerosis	1.03e-05	0.000199	CbGpPWpGaD
Moclobemide—CYP2D6—Metabolism—APOB—atherosclerosis	1.02e-05	0.000197	CbGpPWpGaD
Moclobemide—CYP2C9—Metabolism—APOB—atherosclerosis	1.01e-05	0.000196	CbGpPWpGaD
Moclobemide—CYP2C19—Metabolism—CD36—atherosclerosis	1e-05	0.000195	CbGpPWpGaD
Moclobemide—CYP2D6—Metabolism—GSTM1—atherosclerosis	9.89e-06	0.000192	CbGpPWpGaD
Moclobemide—CYP2C9—Metabolism—GSTM1—atherosclerosis	9.81e-06	0.00019	CbGpPWpGaD
Moclobemide—CYP2D6—Metabolism—LPL—atherosclerosis	9.71e-06	0.000189	CbGpPWpGaD
Moclobemide—CYP2C9—Metabolism—LPL—atherosclerosis	9.63e-06	0.000187	CbGpPWpGaD
Moclobemide—CYP2C19—Metabolism—MTHFR—atherosclerosis	9.51e-06	0.000185	CbGpPWpGaD
Moclobemide—CYP2D6—Metabolism—GPX1—atherosclerosis	9.47e-06	0.000184	CbGpPWpGaD
Moclobemide—CYP2C9—Metabolism—GPX1—atherosclerosis	9.39e-06	0.000182	CbGpPWpGaD
Moclobemide—CYP2C19—Metabolism—PPARA—atherosclerosis	9.33e-06	0.000181	CbGpPWpGaD
Moclobemide—CYP2D6—Metabolism—CD36—atherosclerosis	9.23e-06	0.000179	CbGpPWpGaD
Moclobemide—CYP2C9—Metabolism—CD36—atherosclerosis	9.15e-06	0.000178	CbGpPWpGaD
Moclobemide—CYP2C19—Metabolism—AGT—atherosclerosis	9.03e-06	0.000175	CbGpPWpGaD
Moclobemide—CYP1A2—Metabolism—HMOX1—atherosclerosis	9e-06	0.000175	CbGpPWpGaD
Moclobemide—CYP2C19—Metabolism—APOE—atherosclerosis	8.85e-06	0.000172	CbGpPWpGaD
Moclobemide—CYP2C19—Metabolism—CAV1—atherosclerosis	8.77e-06	0.00017	CbGpPWpGaD
Moclobemide—CYP2C19—Metabolism—APOA1—atherosclerosis	8.75e-06	0.00017	CbGpPWpGaD
Moclobemide—CYP2D6—Metabolism—MTHFR—atherosclerosis	8.74e-06	0.00017	CbGpPWpGaD
Moclobemide—CYP2C9—Metabolism—MTHFR—atherosclerosis	8.67e-06	0.000168	CbGpPWpGaD
Moclobemide—CYP1A2—Metabolism—APOB—atherosclerosis	8.62e-06	0.000167	CbGpPWpGaD
Moclobemide—CYP2D6—Metabolism—PPARA—atherosclerosis	8.58e-06	0.000167	CbGpPWpGaD
Moclobemide—CYP2C9—Metabolism—PPARA—atherosclerosis	8.5e-06	0.000165	CbGpPWpGaD
Moclobemide—CYP1A2—Metabolism—GSTM1—atherosclerosis	8.38e-06	0.000163	CbGpPWpGaD
Moclobemide—CYP2D6—Metabolism—AGT—atherosclerosis	8.31e-06	0.000161	CbGpPWpGaD
Moclobemide—CYP2C9—Metabolism—AGT—atherosclerosis	8.24e-06	0.00016	CbGpPWpGaD
Moclobemide—CYP1A2—Metabolism—LPL—atherosclerosis	8.23e-06	0.00016	CbGpPWpGaD
Moclobemide—CYP2D6—Metabolism—APOE—atherosclerosis	8.14e-06	0.000158	CbGpPWpGaD
Moclobemide—CYP2C9—Metabolism—APOE—atherosclerosis	8.07e-06	0.000157	CbGpPWpGaD
Moclobemide—CYP2D6—Metabolism—CAV1—atherosclerosis	8.07e-06	0.000157	CbGpPWpGaD
Moclobemide—CYP2D6—Metabolism—APOA1—atherosclerosis	8.05e-06	0.000156	CbGpPWpGaD
Moclobemide—CYP1A2—Metabolism—GPX1—atherosclerosis	8.03e-06	0.000156	CbGpPWpGaD
Moclobemide—CYP2C9—Metabolism—CAV1—atherosclerosis	8e-06	0.000155	CbGpPWpGaD
Moclobemide—CYP2C19—Metabolism—PIK3CG—atherosclerosis	7.99e-06	0.000155	CbGpPWpGaD
Moclobemide—CYP2C9—Metabolism—APOA1—atherosclerosis	7.98e-06	0.000155	CbGpPWpGaD
Moclobemide—CYP1A2—Metabolism—CD36—atherosclerosis	7.82e-06	0.000152	CbGpPWpGaD
Moclobemide—CYP2C19—Metabolism—PPARG—atherosclerosis	7.71e-06	0.00015	CbGpPWpGaD
Moclobemide—CYP2C19—Metabolism—INS—atherosclerosis	7.56e-06	0.000147	CbGpPWpGaD
Moclobemide—CYP1A2—Metabolism—MTHFR—atherosclerosis	7.41e-06	0.000144	CbGpPWpGaD
Moclobemide—CYP2D6—Metabolism—PIK3CG—atherosclerosis	7.35e-06	0.000143	CbGpPWpGaD
Moclobemide—CYP2C9—Metabolism—PIK3CG—atherosclerosis	7.28e-06	0.000141	CbGpPWpGaD
Moclobemide—CYP1A2—Metabolism—PPARA—atherosclerosis	7.27e-06	0.000141	CbGpPWpGaD
Moclobemide—CYP2D6—Metabolism—PPARG—atherosclerosis	7.09e-06	0.000138	CbGpPWpGaD
Moclobemide—CYP1A2—Metabolism—AGT—atherosclerosis	7.04e-06	0.000137	CbGpPWpGaD
Moclobemide—CYP2C9—Metabolism—PPARG—atherosclerosis	7.03e-06	0.000136	CbGpPWpGaD
Moclobemide—CYP2D6—Metabolism—INS—atherosclerosis	6.95e-06	0.000135	CbGpPWpGaD
Moclobemide—CYP2C19—Metabolism—ALB—atherosclerosis	6.93e-06	0.000135	CbGpPWpGaD
Moclobemide—CYP1A2—Metabolism—APOE—atherosclerosis	6.9e-06	0.000134	CbGpPWpGaD
Moclobemide—CYP2C9—Metabolism—INS—atherosclerosis	6.89e-06	0.000134	CbGpPWpGaD
Moclobemide—CYP1A2—Metabolism—CAV1—atherosclerosis	6.83e-06	0.000133	CbGpPWpGaD
Moclobemide—CYP1A2—Metabolism—APOA1—atherosclerosis	6.82e-06	0.000132	CbGpPWpGaD
Moclobemide—CYP2C19—Metabolism—NOS3—atherosclerosis	6.63e-06	0.000129	CbGpPWpGaD
Moclobemide—MAOA—Metabolism—AKT1—atherosclerosis	6.44e-06	0.000125	CbGpPWpGaD
Moclobemide—CYP2D6—Metabolism—ALB—atherosclerosis	6.38e-06	0.000124	CbGpPWpGaD
Moclobemide—CYP2C9—Metabolism—ALB—atherosclerosis	6.32e-06	0.000123	CbGpPWpGaD
Moclobemide—CYP1A2—Metabolism—PIK3CG—atherosclerosis	6.22e-06	0.000121	CbGpPWpGaD
Moclobemide—CYP2D6—Metabolism—NOS3—atherosclerosis	6.1e-06	0.000118	CbGpPWpGaD
Moclobemide—CYP2C19—Metabolism—PTGS2—atherosclerosis	6.06e-06	0.000118	CbGpPWpGaD
Moclobemide—CYP2C9—Metabolism—NOS3—atherosclerosis	6.05e-06	0.000117	CbGpPWpGaD
Moclobemide—CYP1A2—Metabolism—PPARG—atherosclerosis	6.01e-06	0.000117	CbGpPWpGaD
Moclobemide—CYP1A2—Metabolism—INS—atherosclerosis	5.89e-06	0.000114	CbGpPWpGaD
Moclobemide—CYP2D6—Metabolism—PTGS2—atherosclerosis	5.58e-06	0.000108	CbGpPWpGaD
Moclobemide—CYP2C9—Metabolism—PTGS2—atherosclerosis	5.53e-06	0.000107	CbGpPWpGaD
Moclobemide—CYP1A2—Metabolism—ALB—atherosclerosis	5.4e-06	0.000105	CbGpPWpGaD
Moclobemide—CYP1A2—Metabolism—NOS3—atherosclerosis	5.17e-06	0.0001	CbGpPWpGaD
Moclobemide—CYP1A2—Metabolism—PTGS2—atherosclerosis	4.73e-06	9.18e-05	CbGpPWpGaD
Moclobemide—CYP2C19—Metabolism—AKT1—atherosclerosis	3.05e-06	5.92e-05	CbGpPWpGaD
Moclobemide—CYP2D6—Metabolism—AKT1—atherosclerosis	2.8e-06	5.44e-05	CbGpPWpGaD
Moclobemide—CYP2C9—Metabolism—AKT1—atherosclerosis	2.78e-06	5.4e-05	CbGpPWpGaD
Moclobemide—CYP1A2—Metabolism—AKT1—atherosclerosis	2.37e-06	4.61e-05	CbGpPWpGaD
